Medigap Coverage for Prescription Drugs

Deborah J. Chollet

Mathematica Policy Research Reports from Mathematica Policy Research

Abstract: Testimony notes that the Medigap market is not a good source of coverage for prescription drugs, and there are many reasons to expect that it will become much worse. Discusses advantages that Medicare coverage of prescription drugs may offer to policyholders and insurers in the Medigap market.

Keywords: Medigap; Prescription; Drugs (search for similar items in EconPapers)
Pages: 10
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mathematica.org/-/media/publications/pdfs/chollettestimony.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 404 Not Found (https://www.mathematica.org/-/media/publications/pdfs/chollettestimony.pdf [302 Found]--> https://www.mathematica.org/System/404-page-not-found?ItemNotFound=true)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mpr:mprres:aa442ecebb884c7aacd9a4744e953347

Access Statistics for this paper

More papers in Mathematica Policy Research Reports from Mathematica Policy Research Mathematica Policy Research P.O. Box 2393 Princeton, NJ 08543-2393 Attn: Communications. Contact information at EDIRC.
Bibliographic data for series maintained by Joanne Pfleiderer () and Cindy George ( this e-mail address is bad, please contact ).